Evidence map›Paper›PMID 41914749›Full record

ArticleAntimicrobial agents and chemotherapy2026

The entire

Tsuyoshi Yamada, Mari Maeda, Minami Nakagawa, Takashi Yaguchi, Masaki Ishii, Karine Salamin, Christine Pich-Bavastro, Michel Monod

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Deciphering the genomic landscape ofMicrobial genomics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tsuyoshi YamadaTeikyo University Institute of Medical Mycology, Tokyo, Japan.ORCID 0000-0002-1394-5455
Mari MaedaTeikyo University Institute of Medical Mycology, Tokyo, Japan.
Minami NakagawaResearch Center, Research Division, Nihon Nohyaku Co., Ltd., Osaka, Japan.
Takashi YaguchiMedical Mycology Research Center, Chiba University, Chiba, Japan.ORCID 0000-0002-9697-8470
Masaki IshiiFaculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.ORCID 0000-0003-0687-3147
Karine SalaminDepartment of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Christine Pich-BavastroDepartment of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0002-6526-749X
Michel MonodDepartment of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.ORCID 0000-0002-0695-4003

Funding

Ministry of Education, Culture, Sports, Science and Technology of Japan via a Grant- in- Aid for Scientific Research (C) 23K07793Nihon Nohyaku Co., Ltd. Joint research on the mechanisms of resistance to azole compounds in dermatophytes
6 · The paper itself

Abstract

The resistance of

Indexed as

Antifungal AgentsAzolesDrug Resistance, FungalFungal ProteinsTrichophytonChromosome MappingGene DosageGenome, FungalMicrobial Sensitivity TestsOpen Reading FramesAntifungal AgentsAzolesFungal Proteinsantifungal resistancedermatophytesgene duplicationoptical genome mappingpolycistronic/monocistronic gene expressionTinCYP51BTrichophyton indotineae

Identifiers

PMID41914749
PMCPMC13148020

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.